Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-22T07:13:42.788Z Has data issue: false hasContentIssue false

Comorbidities with Bipolar Disorders: Significance, Recognition, and Management

Published online by Cambridge University Press:  07 November 2014

Extract

Bipolar disorder, particularly bipolar type I disorder, is at least as highly comorbid with other psychiatric and behavioral disorders as any Axis I medical disorder (Slide 1). Two iterations of the National Comorbidity Survey study, which is epidemio-logic-based and not anecdotal evidence from clinical offices and hospital emergency rooms, have shown that these data are reflective of the overall population in the United States and potentially for all other countries across the world.

In particular, if the prevalence rates of all anxiety disorders are grouped together, they are almost as prevalent as bipolar disorder itself, and clinicians rarely see a patient with bipolar disorder who does not have an anxiety disorder. This finding raises the question that anxiety may not be a separate entity, but an additional fundamental component of bipolar symptomatology, at least for a substantial number of patients. Regardless, the role of anxiety in bipolar disorder is unique. Perugi and colleagues studied the time sequence of different anxiety disorders in relation to first presence and clinical recognition of bipolar disorder (Slide 2). In contrast to panic disorder/agoraphobia and obsessive-compulsive disorder (OCD), social anxiety or social phobia was shown to be prevalent in 94.7% of patients prior to onset of hypomania and the clinically recognizable problematic school and home situations before the diagnosis of the bipolar disorder. This finding suggests that there may be some fundamental aspect of social anxiety and other anxiety disorders that is a ties. These patients tend to be more unstable symptomatically and have multiple comorbidities.

Type
Research Article
Copyright
Copyright © Cambridge University Press 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Kessler, RC, Rubinow, DR, Holmes, C, Abelson, JM, Zhao, S.The epidemiology of DSM-III-R bipolar I disorder in a general population survey. Psychol Med. 1997;27(5):1079-1089.CrossRefGoogle Scholar
2.Merikangas, KR, Akiskal, HS, Angst, J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry. 2007;64(5):543-552.CrossRefGoogle ScholarPubMed
3.Perugi, G, Akiskal, HS, Toni, C, Simonini, E. Gemignani, A. The temporal relationship between anxiety disorders and (hypo)mania: a retrospective examination of 63 panic, social phobic and obsessive-compulsive patients with comorbid bipolar disorder. J Affect Disord. 2001;67(1-3):199-206.CrossRefGoogle ScholarPubMed
4.McElroy, SL, Altshuler, LL, Suppes, T, et al. Axis I psychiatric comorbidity and its relationship to historical illness variables in 288 patients with bipolar disorder. Am J Psychiatry. 2001;158(3):420-426.CrossRefGoogle ScholarPubMed
5.Perugi, G, Toni, C. Akiskal, HS. Anxious-bipolar comorbidity. Diagnostic and treatment challenges. Psychiatr Clin North Am. 1999;22(3):565-583.CrossRefGoogle ScholarPubMed
6.Freeman, MP, Freeman, SA, McElroy, SL. The comorbidity of bipolar and anxiety disorders: prevalence, psychobiology, and treatment issues. J Affect Disord. 2002;68(1):1-23.CrossRefGoogle ScholarPubMed
7.Simon, NM, Pollack, MH, Ostacher, MJ, et al. Understanding the link between anxiety symptoms and suicidal ideation and behaviors in outpatients with bipolar disorder. J Affect Disord. 2006;97(1-3):91-99.CrossRefGoogle ScholarPubMed
8.Masi, G, Perugi, G, Toni, C, et al. Predictors of treatment nonresponse in bipolar children and adolescents with manic or mixed episodes. J Child Adolesc Psychopharmacol. 2004;14(3):395-404.CrossRefGoogle ScholarPubMed
9.Diagnostic and Statistical Manual of Mental Disorders. 4th ed, text rev. Washington, DC: American Psychiatric Association: 2000.Google Scholar
10.Grandjean, EM, Aubry, JM. Lithium: updated human knowledge using an evidence-based approach. Part II: Clinical pharmacology and therapeutic monitoring. CNS Drugs. 2009;23(4):331-349.CrossRefGoogle ScholarPubMed
11.Swann, AC, Pazzaglia, P, Nicholls, A, Dougherty, DM, Moeller, FG. Impulsivity and phase of illness in bipolar disorder. J Affect Disord. 2003;73(1-2):105-111.CrossRefGoogle ScholarPubMed
12.Hirschfeld, RM, Lewis, L, Vornik, LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the national depressive and manic-depressive association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64(2):161-174.CrossRefGoogle ScholarPubMed
13.Benazzi, F. Prevalence of bipolar II disorder in outpatient depression: a 203-case study in private practice. J Affect Disord. 1997;43(2):163-166.CrossRefGoogle ScholarPubMed
14.Hantouche, EG, Akiskal, HS, Lancrenon, S, et al. Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord 1998;50(2-3):163-173.CrossRefGoogle ScholarPubMed
15.Bowden, CL. Strategies to reduce misdiagnosis of bipolar depression. Psychiatr Serv. 2001;52(1):51-55.CrossRefGoogle ScholarPubMed
16.Sato, T, Bottlender, R, Schröter, A, Möller, HJ. Frequency of manic symptoms during a depressive episode and unipolar ‘depressive mixed state’ as bipolar spectrum. Ada Psychiatr Scand. 2003:107(4):268-274.CrossRefGoogle ScholarPubMed